BMY

Bristol-Myers Squibb
D

BMY

Arincen68/100B

Bristol-Myers Squibb total debt 1987–2026

Bristol-Myers Squibb's total debt was 44.81B USD on 30 September 2026, down 12.2% on a year before. At the end of fiscal year 2025 it was 47.14B USD.

Last updated 12 Nov 2026 · Next report 4 Feb 2027

Total debt

Growth

Fiscal yearPeriod endingTotal debtGrowthCash and short-term investmentsNet cashDebt to equity
Latest quarter30 Sept 202644.81B-12.21%12.58B-32.23B1.91
FY202531 Dec 202547.14B-7.93%10.67B-36.47B2.55
FY202431 Dec 202451.20B+23.48%10.86B-40.34B3.13
FY202331 Dec 202341.46B+1.83%12.28B-29.18B1.41
FY202231 Dec 202240.72B-10.70%9.25B-31.46B1.31
FY202131 Dec 202145.60B-11.76%17.22B-28.38B1.27
FY202031 Dec 202051.67B+8.70%16.45B-35.22B1.37
FY201931 Dec 201947.54B+546.86%15.39B-32.15B0.92
FY201831 Dec 20187.35B-7.70%8.76B1.41B0.52
FY201731 Dec 20177.96B+18.69%6.81B-1.15B0.68
FY201631 Dec 20166.71B+0.28%6.35B-358.00M0.41
FY201531 Dec 20156.69B-14.59%4.27B-2.42B0.47
FY201431 Dec 20147.83B-6.09%7.44B-397.00M0.53
FY201331 Dec 20138.34B+12.79%4.53B-3.82B0.55
FY201231 Dec 20127.39B+34.66%2.83B-4.57B0.54
FY201131 Dec 20115.49B+0.84%8.73B3.24B0.34
FY201031 Dec 20105.45B-14.40%7.30B1.86B0.35
FY200931 Dec 20096.36B-5.61%8.51B2.15B0.43
FY200831 Dec 20086.74B+7.45%8.27B1.53B0.55
FY200731 Dec 20076.27B-15.64%2.23B-4.05B0.59
FY200631 Dec 20067.44B-13.50%4.01B-3.42B0.74
FY200531 Dec 20058.60B-16.92%5.80B-2.80B0.77
FY200431 Dec 200410.35B+18.19%7.47B-2.87B1.01
FY200331 Dec 20038.75B+14.58%5.56B-3.19B0.89
FY200231 Dec 20027.64B+19.17%3.99B-3.65B0.87
FY200131 Dec 20016.41B+327.97%5.65B-757.00M0.71
FY200031 Dec 20001.50B-15.56%3.39B1.89B0.16
FY199931 Dec 19991.77B-3.90%2.96B1.18B0.21
FY199831 Dec 19981.85B+1.32%2.24B398.00M0.24
FY199731 Dec 19971.82B+23.19%1.46B-366.00M0.25
FY199631 Dec 19961.48B+22.23%1.68B202.00M0.23
FY199531 Dec 19951.21B-11.61%1.65B435.00M0.21
FY199431 Dec 19941.37B+78.95%1.64B273.00M0.24
FY199331 Dec 1993765.00M+38.84%2.42B1.66B0.13
FY199231 Dec 1992551.00M-19.91%2.14B1.59B0.09
FY199131 Dec 1991688.00M+9.55%1.44B747.00M0.12
FY199031 Dec 1990628.00M+21.24%596.00M-32.00M0.12
FY198931 Dec 1989518.00M-46.21%510.00M-8.00M0.10
FY198831 Dec 1988963.00M+38.76%2.51B1.55B0.19
FY198731 Dec 1987694.00M—2.35B1.65B0.15

Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.

Total debt counts commercial paper, term debt and lease liabilities.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Free cash flow,Stock buybacks,Balance sheet

Common questions about Bristol-Myers Squibb's debt

Source: Financial Modeling PrepVerified against SEC filings